Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly…
Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a…
DELRAY BEACH, Fla., May 9, 2025 /PRNewswire/ -- The global Artificial Intelligence (AI) in Healthcare Market, valued at US$14.92 billion…
EAGAN, Minn., May 9, 2025 /PRNewswire/ -- ImageTrend, a leading provider of cloud-based software solutions for EMS, fire, and hospital…
One Verseon paper covers a new method to compensate for missing or imperfect data and another covers Verseon's AutoESSV method…
BUDAPEST, Hungary, May 9, 2025 /PRNewswire/ -- Mediso is pleased to announce the successful completion of the first phase of…
Innovative platform recognized for improving practice operations, improving patient engagement, and reducing administrative burden for healthcare practices NEW YORK, May…
WASHINGTON, May 9, 2025 /PRNewswire/ -- Dr. Edward Robb, Chief Strategy Officer, Anivive Lifesciences presented their pioneering research update on…
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical…
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2025 (GLOBE…
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering…
TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global…
Backed by Wolfson Brands (UK) Limited, discover proven bodybuilding supplements & legal steroids that actually work. Build lean muscle, burn…
Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase…
Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing…
New corporate identity reflects the continued evolution toward developing the Stratus Prime™ platform to deliver on-demand, Prime HSCs™ and Prime…
DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,…
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53…
Jason Keyes is a veteran corporate executive within the biopharmaceutical industry who brings a breadth of leadership experience in the…
